RSV F PROTEIN-MUTANTEN

Patent europeic · EP3393512 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3393512
Numer da la dumonda
EP16816405
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
09-12-2016
Publitgà
31-10-2018
Concedì
19-11-2025
La protecziun finescha il pli tard
08-12-2036
Proxima taxa annuala scadenta
31-12-2026
Classas IPC
A61K 39/155 (2006.01)
A61K 39/12 (2006.01)
C07K 14/005 (2006.01)
Prioritad
US 201562387270 P 23.12.2015
US 201662421184 P 11.11.2016
Dumonda PCT
PCT/IB2016/057502 09.12.2016
Publicaziun PCT
WO2017/109629 29.06.2017
Lingua da l’annunzia
englais
Funtauna
Swissreg

Certificats cumplementars da protecziun

In certificat prolunghescha la protecziun dal patent per in medicament u in product da protecziun da plantas admess en Svizra.

RSV Subgruppe B Glycoprotein F stabilisiert in der Präfusionskonformation

C03393512/03 · Medicament · Dumonda · Protecziun dals 09-12-2036 fin ils 22-08-2039

Admissiun 69691 (Swissmedic, 23-08-2024)

RSV Subgruppe A Glycoprotein F stabilisiert in der Präfusionskonformation

C03393512/02 · Medicament · Dumonda · Protecziun dals 09-12-2036 fin ils 22-08-2039

Admissiun 69691 (Swissmedic, 23-08-2024)

RSV Subgruppe A Glycoprotein F stabilisiert in der Präfusionskonformation und RSV Subgruppe B Glycoprotein F stabilisiert in der Präfusionskonformation

C03393512/01 · Medicament · Dumonda · Protecziun dals 09-12-2036 fin ils 22-08-2039

Admissiun 69691 (Swissmedic, 23-08-2024)

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 30-09-2026

    Midada

    Published in Swissreg on 30.09.2026

  2. 01-01-2026

    Next annual fee due on

    Next annual fee due on
    31.12.2025 → 31.12.2026

    Published in Swissreg on 01.01.2026

  3. 20-11-2025

    Represchentant inscrit

    Representative
    E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 20.11.2025

  4. 19-11-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 19.11.2025

Partidas

Possessur

Pfizer Inc.

66 Hudson Boulevard East, New York, NY 10001-2192, US

Represchentant

E. Blum & Co. AG

Hofwiesenstrasse 349, 8050 Zürich

Inventur

CHE, Ye

Groton CT 06340, US

DORMITZER, Philip Ralph

Armonk NY 10504, US

GRIBENKO, Alexey Vyacheslavovich

New City NY 10956, US

HANDKE, Luke David

Nyack NY 10960, US

PRASAD, Avvari Krishna

Chapel Hill NC 27516, US

QIU, Xiayang

Mystic CT 06355, US

RUPPEN, Mark Edward

Garnerville NY 10932, US

SONG, Xi

Waterford CT 06385, US

SWANSON, Kena Anne

Pearl River NY 10965, US

KODALI, Srinivas

Hillsborough NJ 08844, US

XU, Xin

Mahwah NJ 07430, US

EFFEREN, KariAnn Sweeney

Stamford CT 06905, US

CAI, Ping

New City NY 10956, US

TOMPKINS, Kristin Rachael

Garrison NY 10524, US

NUNEZ, Lorna Del Pilar

Briarcliff Manor NY 10510, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.